Cost of allogeneic and autologous blood transfusion in Canada

被引:0
作者
Tretiak, R
Laupacis, A
Riviere, M
McKerracher, K
Souetre, E
机构
[1] OTTAWA CIVIC HOSP,LOEB MED RES INST,CLIN EPIDEMIOL UNIT,OTTAWA,ON,CANADA
[2] ORTHO BIOTECH,DON MILLS,ON,CANADA
[3] BENEFIT RES GRP,GENNEVILLIERS,FRANCE
[4] UNIV ALBERTA HOSP,EDMONTON,AB T6G 2B7,CANADA
[5] VANCOUVER HOSP & HLTH SCI CTR,VANCOUVER,BC,CANADA
[6] OSHAWA GEN HOSP,OSHAWA,ON,CANADA
[7] HOP NOTRE DAME DE BON SECOURS,MONTREAL,PQ H2L 4K8,CANADA
[8] SUNNYBROOK HLTH SCI CTR,N YORK,ON,CANADA
[9] HOP ST FRANCOIS ASSISE,QUEBEC CITY,PQ,CANADA
[10] ROYAL INLAND HOSP,KAMLOOPS,BC,CANADA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the cost, from a societal perspective, of blood transfusion in Canada. Study design: Cost-structure analysis. Setting: Data were collected from eight hospitals and from six blood centres operated by the Canadian Red Cross Society in four provinces. Outcome measures: Costs associated with four stages of transfusion - collection, production, distribution and delivery - in 1993 were assessed. Costs were divided into the following categories: personnel, purchases, external services, overhead, donors' time, patients' time (for autologous transfusion), wastage and infection. Results: The mean overall cost of a transfusion performed on an inpatient basis was $210 per unit of red blood cells for an allogeneic transfusion and $338 per unit of blood for an autologous transfusion. The mean cost of an allogeneic transfusion performed on an outpatient basis was $280 per unit of red blood cells. Conclusion: The costs determined in this study can be used in future studies comparing the cost-effectiveness of allogeneic transfusion with that of alternative methods.
引用
收藏
页码:1501 / 1508
页数:8
相关论文
共 50 条
[21]   AUTOLOGOUS BLOOD-TRANSFUSION - EVALUATION OF AN ALTERNATIVE STRATEGY IN REDUCING EXPOSURE TO ALLOGENEIC BLOOD-TRANSFUSION [J].
QUTAISHAT, S .
IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (1-2) :435-441
[22]   Allogeneic versus autologous blood transfusion and survival after radical prostatectomy [J].
Chalfin, Heather J. ;
Frank, Steven M. ;
Feng, Zhaoyong ;
Trock, Bruce J. ;
Drake, Charles G. ;
Partin, Alan W. ;
Humphreys, Elizabeth ;
Ness, Paul M. ;
Jeong, Byong C. ;
Lee, Seung B. ;
Han, Misop .
TRANSFUSION, 2014, 54 (09) :2168-2174
[23]   Immunosuppressive effect of autologous or allogeneic blood transfusion in orthopedic surgical patients [J].
Misso, S. ;
Feol, B. ;
D'Onofrio, M. ;
Paesano, L. ;
Fratellanza, G. .
VOX SANGUINIS, 2006, 91 :315-315
[24]   Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion [J].
Boulton, F. E. ;
James, V. .
TRANSFUSION MEDICINE, 2007, 17 (05) :354-365
[25]   Blood transfusion strategies for total knee arthroplasty - Minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost [J].
Knight, JL ;
Sherer, D ;
Guo, J .
JOURNAL OF ARTHROPLASTY, 1998, 13 (01) :70-76
[26]   Is Autologous Blood Transfusion cost effective in Adolescent Idiopathic Scoliosis? [J].
Sanpera, Ignacio, Jr. ;
Burgos-Flores, Jesus ;
Garcia, Vicente ;
Barrios, Carlos ;
Piza-Vallespir, Gabriel ;
Anton-Rodrigalvarez, Luis M. .
ACTA ORTHOPAEDICA BELGICA, 2016, 82 (04) :901-906
[27]   The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion [J].
Sonnenberg, FA ;
Gregory, P ;
Yomtovian, R ;
Russell, LB ;
Tierney, W ;
Kosmin, M ;
Carson, JL .
TRANSFUSION, 1999, 39 (08) :808-817
[28]   The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion [J].
Vamvakas, EC .
TRANSFUSION, 2000, 40 (03) :384-386
[29]   A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood [J].
Roberts, WA ;
Kirkley, SA ;
Newby, M .
ANESTHESIA AND ANALGESIA, 1996, 83 (01) :129-133
[30]   CONTROVERSIES IN TRANSFUSION MEDICINE - IS AUTOLOGOUS BLOOD-TRANSFUSION WORTH THE COST - PRO - REPLY [J].
GOLDFINGER, D ;
HAIMOWITZ, MD .
TRANSFUSION, 1994, 34 (08) :737-737